Par Pharmaceutical Inc. recalls BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Recalled September 2, 2020 · FDA recall D-1542-2020 · Par Pharmaceutical
Hazard
Failed Impurity /Degradation Specifications · FDA Class II
Units
11,347 bottles
Sold at
Product was distributed to 9 major distributors throughout the United States.
Description
Failed Impurity /Degradation Specifications
Product
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Manufacturer(s)
Par Pharmaceutical Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →